Pseudomonas bacteremia. Evaluation of factors influencing response to therapy.
D001412:Bacillus subtilis / Q000378:metabolism; D001681:Biological Assay; D002228:Carbenicillin / Q000494:pharmacology; D003404:Creatinine / Q000097:blood; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004926:Escherichia coli / Q000187:drug effects; D005839:Gentamicins / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D006207:Half-Life; D006801:Humans; D066298:In Vitro Techniques; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007711:Klebsiella pneumoniae / Q000187:drug effects; D011514:Proteus vulgaris / Q000187:drug effects; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D018805:Sepsis / Q000188:drug therapy*; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors
D005839:Gentamicins; D013256:Steroids; D003404:Creatinine; D002228:Carbenicillin